Video Experimental Relacionado
Updated: Sep 9, 2025
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
33.5K
Evaluación preclínica de una combinación de metformina y melatonina: sinergia antinociceptiva
Marcia Yvette Gauthereau-Torres1, Jenny Selene Martínez-Guillen1, Claudia Cervantes-Durán2
1División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas "Dr. Ignacio Chávez", Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58020, Mexico.
Pharmaceutics
|August 28, 2025
Resumen
La combinación de metformina y melatonina muestra un alivio sinérgico del dolor en ratas, ofreciendo un nuevo tratamiento potencial para el dolor inflamatorio. Esta combinación mejora los efectos analgésicos y reduce potencialmente los efectos secundarios.
Área de la Ciencia:
- Farmacología
- Tratamiento del dolor
- Interacciones farmacológicas
Sus antecedentes:
- El dolor es un problema de salud global significativo.
- Las combinaciones de medicamentos pueden mejorar la eficacia y reducir los efectos secundarios.
- La metformina y la melatonina exhiben propiedades analgésicas potenciales.
Objetivo del estudio:
- Evaluar la interacción farmacológica entre la metformina y la melatonina.
- Evaluar los efectos sinérgicos o antagónicos de la combinación de metformina y melatonina.
- Investigar los mecanismos subyacentes y el perfil de seguridad del tratamiento combinado.
Principales métodos:
- Prueba de formalina en un modelo de rata para inducir y medir el dolor.
- Administración oral de metformina, melatonina y su combinación.
- Análisis isobolográfico para determinar las interacciones farmacológicas.
- Estudios de antagonistas de los receptores (AMPK, MT2, opioides) y prueba de seguridad con rotarod.
Principales resultados:
- La combinación de metformina y melatonina demostró efectos antinociceptivos significativos en la prueba de formalina.
- El análisis isobolográfico reveló una interacción sinérgica, con una ED50 experimental más baja que la teórica.
- La eficacia de la combinación involucra las vías opioidérgicas, los receptores MT2 y la activación de AMPK.
Conclusiones:
- La administración oral concomitante de metformina y melatonina muestra efectos analgésicos sinérgicos.
- Esta combinación representa una estrategia terapéutica prometedora para el tratamiento del dolor inflamatorio.
- Investigaciones adicionales pueden validar esta combinación como una nueva opción de tratamiento.
Videos de Conceptos Relacionados
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
238
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
238
01:19Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
01:25Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
01:27Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K